Trials / Unknown
UnknownNCT00366119
Safety and Efficacy of Ramipril in the Treatment of Essential Hypertension
Phase 4 Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Ramiprin Tab. in Essential Hypertension
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 86 (planned)
- Sponsor
- Pacific Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess which drug is more effective of Ramiprin®(ramipril) and Tritace®(ramipril) in the Treatment of Essential Hypertension
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ramipril |
Timeline
- Start date
- 2006-06-01
- Completion
- 2007-06-01
- First posted
- 2006-08-18
- Last updated
- 2007-03-09
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00366119. Inclusion in this directory is not an endorsement.